Silvia E. Jiménez

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Efficacy of the bivalent HPV vaccine against HPV 16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine Trial”.

Efficacy of the bivalent HPV vaccine against HPV 16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine Trial

The Lancet Oncology(2020)10.1016/s1470-2045(20)30524-6

N/A

4.1DataRank · unranked

133 citations

Sabrina H. Tsang, Rolando Herrero, Diego Guillén, Teresa M. Darragh, Mark H. Stoler +26 more

Precancerous cervical lesions caused by non-vaccine-preventable HPV types after vaccination with the bivalent AS04-adjuvanted HPV vaccine: an analysis of the long-term follow-up study from the randomised Costa Rica HPV Vaccine Trial

The Lancet Oncology(2022)10.1016/s1470-2045(22)00291-1

N/A

1.9DataRank · unranked

53 citations

Shangying Hu, Rolando Herrero, Allan Hildesheim, Carolina Porras, Joshua N. Sampson +23 more

molBV reveals immune landscape of bacterial vaginosis and predicts human papillomavirus infection natural history

Nature Communications(2022)10.1038/s41467-021-27628-3

N/A

1.8DataRank · unranked

64 citations

Nicolas F. Schlecht, Sarah Pickering, LaShanda Williams, Christopher C. Sollecito, Ana Gradíssimo +30 more

Estimating human papillomavirus vaccine efficacy from a single-arm trial: proof-of-principle in the Costa Rica Vaccine Trial

JNCI Journal of the National Cancer Institute(2023)10.1093/jnci/djad064

N/A

0.355DataRank · unranked

5 citations

Nicole G. Campos, Didem Egemen, Rolando Herrero, Mark Schiffman, Carolina Porras +26 more

Differential long-term bivalent HPV vaccine cross-protection by variants in the Costa Rica HPV vaccine trial

npj Vaccines(2024)10.1038/s41541-024-00896-y

N/A

0DataRank · unranked

9 citations

Carolina Porras, Maísa Pinheiro, Rolando Herrero, Allan Hildesheim, Danping Liu +37 more

Risk Factors for Non–Human Papillomavirus (HPV) Type 16/18 Cervical Infections and Associated Lesions Among HPV DNA–Negative Women Vaccinated Against HPV-16/18 in the Costa Rica Vaccine Trial

The Journal of Infectious Diseases(2020)10.1093/infdis/jiaa768

N/A

0DataRank · unranked

10 citations

Sabrina H. Tsang, Shangying Hu, Carolina Porras, Rolando Herrero, Aimée R. Kreimer +26 more

HPV16 infection decreases vaccine-induced HPV16 antibody avidity: the CVT trial

npj Vaccines(2022)10.1038/s41541-022-00431-x

N/A

0DataRank · unranked

10 citations

John T. Schiller, Carolina Porras, Troy J. Kemp, Rolando Herrero, John Schussler +26 more

HPV16/18 antibodies 16-years after single dose of bivalent HPV vaccination: Costa Rica HPV vaccine trial

JNCI Monographs(2024)10.1093/jncimonographs/lgae032

N/A

0DataRank · unranked

31 citations

Byron Romero, Troy J. Kemp, Romain Fantin, Rolando Herrero, Allan Hildesheim +26 more